LAP3 and neoplasm: Co-administration of stabilizing agents such as peptidase inhibitor phosphoramidon have been suggested to increase tumor-to-organ ratios by increasing peptide stability [30], yet this may not be applicable for 68Ga-NeoBOMB1 in face of the already high in vivo plasma stability [25,31].